Epigral Future Growth
Future criteria checks 4/6
Epigral is forecast to grow earnings and revenue by 19.1% and 16.5% per annum respectively. EPS is expected to grow by 19.2% per annum. Return on equity is forecast to be 22.3% in 3 years.
Key information
19.1%
Earnings growth rate
19.2%
EPS growth rate
Chemicals earnings growth | 22.8% |
Revenue growth rate | 16.5% |
Future return on equity | 22.3% |
Analyst coverage | Low |
Last updated | 24 Jul 2024 |
Recent future growth updates
No updates
Recent updates
Epigral Limited's (NSE:EPIGRAL) Shares Leap 29% Yet They're Still Not Telling The Full Story
Jul 04Epigral Limited (NSE:EPIGRAL) Looks Just Right With A 27% Price Jump
Apr 19Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward
Feb 23Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively
Feb 21Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong
Apr 05With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case
Sep 28Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations
May 03Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price
Nov 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 34,536 | 4,552 | 3,460 | 6,460 | 1 |
3/31/2026 | 31,851 | 4,007 | 2,761 | 5,761 | 1 |
3/31/2025 | 26,146 | 3,037 | 1,350 | 4,350 | 1 |
9/30/2024 | 22,734 | 2,935 | 1,751 | 4,323 | N/A |
6/30/2024 | 21,255 | 2,502 | N/A | N/A | N/A |
3/31/2024 | 19,292 | 1,959 | -8 | 3,976 | N/A |
12/31/2023 | 19,667 | 1,953 | N/A | N/A | N/A |
9/30/2023 | 20,331 | 2,234 | 679 | 5,174 | N/A |
6/30/2023 | 21,104 | 2,770 | N/A | N/A | N/A |
3/31/2023 | 21,884 | 3,533 | 2,097 | 6,262 | N/A |
12/31/2022 | 21,250 | 3,756 | N/A | N/A | N/A |
9/30/2022 | 20,093 | 3,682 | 155 | 4,202 | N/A |
6/30/2022 | 17,934 | 3,236 | N/A | N/A | N/A |
3/31/2022 | 15,509 | 2,528 | -1,725 | 2,838 | N/A |
3/31/2021 | 8,286 | 1,008 | 324 | 2,292 | N/A |
3/31/2020 | 6,098 | 1,141 | -2,046 | 1,646 | N/A |
3/31/2019 | 7,104 | 1,828 | -413 | 2,613 | N/A |
3/31/2018 | 5,975 | 1,555 | N/A | 2,249 | N/A |
3/31/2017 | 3,921 | 665 | N/A | 1,385 | N/A |
3/31/2016 | 3,982 | 672 | N/A | 1,234 | N/A |
3/31/2015 | 3,518 | 347 | N/A | 1,122 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EPIGRAL's forecast earnings growth (19.1% per year) is above the savings rate (6.7%).
Earnings vs Market: EPIGRAL's earnings (19.1% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: EPIGRAL's earnings are forecast to grow, but not significantly.
Revenue vs Market: EPIGRAL's revenue (16.5% per year) is forecast to grow faster than the Indian market (10.4% per year).
High Growth Revenue: EPIGRAL's revenue (16.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EPIGRAL's Return on Equity is forecast to be high in 3 years time (22.3%)